Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: From I-hub-Dutton, "raising our price target to $0.90 per share"
Reply New Message
Back To Forum List View
From I-hub-Dutton, "raising our price target to $0.90 per share"
3
wolfpackvolt
Dec 11, 2007 08:35AM

Is Dutton trying to make us think there is something significant about a market value of $352.0 million??? 

 

Personally, I think they are just taking this opportunity to show the investment community that they have finally figured out how to use one of them high-falootin' kalikulaters.  IMPRESSIVE!

2 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply